Skip to content
Business Company News, Medical Health Aged Care

Professor Peter van Wijngaarden to become next Director and CEO of The Florey

The Florey 2 mins read

The Florey Board appoints new Director and CEO  

After an extensive global search, Professor Peter van Wijngaarden has been named as the next Director and CEO of The Florey Institute of Neuroscience and Mental Health. 

Board Chair Mr Martin Adams said Professor van Wijngaarden is an outstanding leader and an experienced clinician researcher who will take The Florey’s work to the world stage. 

“On behalf of the Board, I warmly welcome Peter to The Florey. As the largest brain research centre in the Southern Hemisphere, The Florey is home to remarkably talented people committed to advancing neuroscience and mental health research. Peter is exceptionally well-placed to take The Florey’s impact to the next level.” 

Professor van Wijngaarden said he was looking forward to taking up his new role next month. 

“I am honoured to be joining The Florey as its new Director and excited to be working with scientists who are leading the world in making fundamental discoveries in neuroscience and improving diagnostics and treatments for an impressive range of mental health and brain-related conditions,” Professor van Wijngaarden said.  

“The Florey has an incredible reputation and I look forward to building on that impressive legacy,” he said. 

Mr Adams thanked retiring Director Professor Trevor Kilpatrick for his leadership and commitment to the organisation.  

"Trevor has done an outstanding job leading The Florey through a period of important structural changes which have positioned us to continue to make significant scientific breakthroughs with our partners. I’m confident that Peter will build upon these efforts.”  

Professor Kilpatrick said he was proud to have served The Florey as its sixth Director. 

“I’m delighted that Professor van Wijngaarden has accepted this appointment,” Professor Kilpatrick said.  

“I have known Peter since his return from Cambridge where he undertook research in regenerative neuroscience with my long-term friend and colleague Professor Robin Franklin. 

“Since then, Peter has had a stellar career as a clinician scientist, administrator and entrepreneur. He is ideally placed to lead The Florey in the next phase of its journey as a world-leading neuroscience and mental health-oriented research institute.” 

Peter is Professor of Ophthalmology at the University of Melbourne and has served as Deputy Director at the Centre for Eye Research Australia (CERA). 

His research interests include retinal imaging, artificial intelligence, multiple sclerosis and Alzheimer’s disease. 

 


Key Facts:
  • Professor Peter van Wijngaarden has been selected to lead The Florey from 1 August 2024 

  • Professor van Wijngaarden is currently Deputy Director of the Centre for Eye Research Australia 


About us:

The Florey is Australia’s leading brain research institute with a focus on improving the lives of people with neurological and psychiatric conditions. The Florey’s research missions are centred around dementia, epilepsy, mental health and developing ways to protect and repair the brain. These missions are strengthened by The Florey’s expertise in neurotherapeutics, neuroimaging, synaptic biology and systems neuroscience. With 600 researchers, The Florey is the largest research centre of its kind in the southern hemisphere.

Find out more about us on our website: www.florey.edu.au


Contact details:

Kathryn Powley, Media and Communications Manager

[email protected] | 0456 666 271

Media

More from this category

  • Business Company News, Medical Health Aged Care
  • 29/12/2025
  • 11:19
Chapter One Advisors

Memphasys Secures CE Mark Approval for Felix(TM) System, Marking Commercial Inflection Point and Activating Global Growth Strategy

HIGHLIGHTS CE Mark approval achieved for the Felix™ System under EU MDR, unlocking full commercial deployment across Europe and other CE-recognised international markets. Immediate…

  • Contains:
  • Business Company News, Manufacturing
  • 29/12/2025
  • 10:20
Jane Morgan Management

Temas Resources (ASX:TIO) Completes High-Resolution LiDAR Survey, Accelerates Development Planning for Québec Projects

29 December 2025 – Vancouver, Canada | Temas Resources Limited (ASX:TIO) (“Temas” or the “Company”) has today announced the completion of a high-resolution airborne LiDAR survey across its La Blache and Lac Brule Projects in Québec, Canada. This milestone will assist Temas in accelerating engineering, feasibility planning and the future development activities at each of the assets. The survey covered ~46.05km2 and delivered engineering-grade topographic data beneath dense forest cover. The data provides a detailed digital elevation model suitable for geological and structural interpretation, mineral resource estimation, infrastructure design and environmental baseline studies. The LiDAR dataset integrates with recently completed…

  • Contains:
  • Medical Health Aged Care, National News Current Affairs
  • 29/12/2025
  • 06:40
Australian Dental Association

PROPOSED PLAN TO INCREASE DENTIST NUMBERS COULD PUT PATIENT SAFETY AT RISK

29.12.25 PROPOSED PLAN TO INCREASE DENTIST NUMBERS COULD PUT PATIENT SAFETY AT RISK ADA urging fixing current system instead A new plan to allow…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.